NCT06392282View on ClinicalTrials.gov

MV-140 Efficacy in Recurrent Urinary Tract Infections in a Cohort of Portuguese Adult Patients

Active, not recruitingOBSERVATIONAL

Enrollment

104

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

Urinary Tract Infections

Interventions

DRUG

MV-140

MV-140 use - sublingual spray approved for recurrent UTI prevention

Trial Locations (1)

1649

Hospital de Santa Maria, Lisbon

All Listed Sponsors

lead

Unidade Local de Saúde Santa Maria

OTHER_GOV